Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
Lancet (London, England)|April 28, 2023
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trialHarry P Erba, Pau Montesinos, Hee-Je Kim, et al.
Transplantation and Cellular Therapy|November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
The Lancet. Oncology|June 4, 2018
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trialJorge Cortes, Alexander E Perl, Hartmut Döhner, et al.
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Cancer Biology & Therapy|February 18, 2010
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hoursAnthony R Mato, Selina M Luger, Daniel F Heitjan, et al.
Blood Advances|May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
JAMA Oncology|February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 TrialAnand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Nature Communications|September 18, 2024
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemiaCheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, et al.
Future Oncology (London, England)|July 11, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD-negative acute myeloid leukemiaPau Montesinos, Jessica K Altman, Lars Bullinger, et al.
Pageof 19